1	LPS-Induced	lps-induced	_	_	_	_	_	_	_
2	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
6	release	release	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	monocytes	monocyte	_	_	_	_	_	_	_
10	are	be	_	_	_	_	_	_	_
11	protein	protein	_	_	_	_	_	_	_
12	tyrosine	tyrosine	_	_	_	_	_	_	_
13	kinase	kinase	_	_	_	_	_	_	_
14	dependent	dependent	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	protein	protein	_	_	_	_	_	_	_
17	kinase	kinase	_	_	_	_	_	_	_
18	C	C	_	_	_	_	_	_	_
19	independent	independent	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Tumor	tumor	_	_	_	_	_	_	_
4	necrosis	necrosis	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	alpha	alpha	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	important	important	_	_	_	_	_	_	_
13	mediator	mediator	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	septic	septic	_	_	_	_	_	_	_
16	shock	shock	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Endotoxin	Endotoxin	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	LPS	LPS	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	signal	signal	_	_	_	_	_	_	_
6	transduction	transduction	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	monocytes	monocyte	_	_	_	_	_	_	_
10	leads	lead	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	nuclear	nuclear	_	_	_	_	_	_	_
15	factor-kappa	factor-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
22	release	release	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	implicated	implicate	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	both	both	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	kinase	kinase	_	_	_	_	_	_	_
10	C	C	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	PKC	PKC	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	protein	protein	_	_	_	_	_	_	_
16	tyrosine	tyrosine	_	_	_	_	_	_	_
17	kinases	kinase	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	PTK	PTK	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	LPS-induced	lps-induced	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
27	production	production	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	hypothesized	hypothesize	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	inhibition	inhibition	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	either	either	_	_	_	_	_	_	_
7	PKC	PKC	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	PTK	PTK	_	_	_	_	_	_	_
10	would	would	_	_	_	_	_	_	_
11	decrease	decrease	_	_	_	_	_	_	_
12	LPS-induced	lps-induced	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	DNA	DNA	_	_	_	_	_	_	_
15	binding	binding	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
18	release	release	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	monocytes	monocyte	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	MATERIALS	MATERIALS	_	_	_	_	_	_	_
2	AND	and	_	_	_	_	_	_	_
3	METHODS	METHODS	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	Human	human	_	_	_	_	_	_	_
6	monocytes	monocyte	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	stimulated	stimulate	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	PMA	PMA	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	50	50	_	_	_	_	_	_	_
13	ng/ml	ng/ml	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	alone	alone	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	LPS	LPS	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	100	100	_	_	_	_	_	_	_
20	ng/ml	ng/ml	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	without	without	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	nonspecific	nonspecific	_	_	_	_	_	_	_
27	serine/threonine	serine/threonine	_	_	_	_	_	_	_
28	protein	protein	_	_	_	_	_	_	_
29	kinase	kinase	_	_	_	_	_	_	_
30	inhibitor	inhibitor	_	_	_	_	_	_	_
31	staurosporine	staurosporine	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	Stauro	Stauro	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	a	a	_	_	_	_	_	_	_
37	specific	specific	_	_	_	_	_	_	_
38	pan-PKC	pan-pkc	_	_	_	_	_	_	_
39	inhibitor	inhibitor	_	_	_	_	_	_	_
40	bisindolylmaleimide	bisindolylmaleimide	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	Bis	Bis	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	or	or	_	_	_	_	_	_	_
46	an	an	_	_	_	_	_	_	_
47	inhibitor	inhibitor	_	_	_	_	_	_	_
48	of	of	_	_	_	_	_	_	_
49	PTK	PTK	_	_	_	_	_	_	_
50	genistein	genistein	_	_	_	_	_	_	_
51	(	(	_	_	_	_	_	_	_
52	Gen	Gen	_	_	_	_	_	_	_
53	)	)	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
2	release	release	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	culture	culture	_	_	_	_	_	_	_
5	supernatants	supernatant	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	measured	measure	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	ELISA	ELISA	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	DNA	DNA	_	_	_	_	_	_	_
3	binding	binding	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	evaluated	evaluate	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	electrophoretic	electrophoretic	_	_	_	_	_	_	_
8	mobility	mobility	_	_	_	_	_	_	_
9	shift	shift	_	_	_	_	_	_	_
10	assay	assay	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	LPS	LPS	_	_	_	_	_	_	_
4	increased	increase	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	DNA	DNA	_	_	_	_	_	_	_
7	binding	binding	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
10	release	release	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	monocytes	monocyte	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Nonspecific	nonspecific	_	_	_	_	_	_	_
2	protein	protein	_	_	_	_	_	_	_
3	kinase	kinase	_	_	_	_	_	_	_
4	inhibition	inhibition	_	_	_	_	_	_	_
5	inhibited	inhibit	_	_	_	_	_	_	_
6	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
10	release	release	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	while	while	_	_	_	_	_	_	_
13	specific	specific	_	_	_	_	_	_	_
14	PKC	PKC	_	_	_	_	_	_	_
15	inhibition	inhibition	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	Bis	Bis	_	_	_	_	_	_	_
18	had	have	_	_	_	_	_	_	_
19	no	no	_	_	_	_	_	_	_
20	effect	effect	_	_	_	_	_	_	_
21	on	on	_	_	_	_	_	_	_
22	LPS-induced	lps-induced	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	DNA	DNA	_	_	_	_	_	_	_
25	binding	binding	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
28	release	release	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	PTK	PTK	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	Gen	Gen	_	_	_	_	_	_	_
5	attenuated	attenuate	_	_	_	_	_	_	_
6	both	both	_	_	_	_	_	_	_
7	LPS-induced	lps-induced	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	DNA	DNA	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
13	production	production	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	monocytes	monocyte	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Direct	direct	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	PKC	PKC	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	PMA	PMA	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	both	both	_	_	_	_	_	_	_
9	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
13	production	production	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	monocytes	monocyte	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	These	these	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	suggest	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	LPS-induced	lps-induced	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
12	release	release	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	human	human	_	_	_	_	_	_	_
15	monocytes	monocyte	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	independent	independent	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	PKC	PKC	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	our	our	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	provide	provide	_	_	_	_	_	_	_
6	evidence	evidence	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	PTK	PTK	_	_	_	_	_	_	_
9	plays	play	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	LPS-induced	lps-induced	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
18	release	release	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	monocytes	monocyte	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	thus	thus	_	_	_	_	_	_	_
24	could	could	_	_	_	_	_	_	_
25	be	be	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	potential	potential	_	_	_	_	_	_	_
28	therapeutic	therapeutic	_	_	_	_	_	_	_
29	target	target	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	inflammatory	inflammatory	_	_	_	_	_	_	_
32	states.	states.	_	_	_	_	_	_	_
33	Copyright	Copyright	_	_	_	_	_	_	_
34	1999	1999	_	_	_	_	_	_	_
35	Academic	Academic	_	_	_	_	_	_	_
36	Press	Press	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

